Healthcare Global September 14, 2020
Kayleigh Shooter

We examine McKinsey’s five step road map to a stronger healthcare supply chain.

The manufacturing of pharmaceuticals and medical devices is growing more and more complex, which has been amplified by the COVID-19 pandemic. Businesses are forever expanding their innovation portfolios to meet the constantly changing markets and product life cycles. One thing accelerating the change is the fact that emerging/developing economies tend to want more affordable products. Quality and compliance issues are on the rise due to products being more complex and regulatory scrutiny becoming stricter. In addition, the number of drug recalls is increasing. However, the medical supply chain continues to be quite fragmented and incomplete, weaknesses in the supply chain can put patients at risk or cost...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Provider, Supply Chain, Technology
Amazon Business helps evolve the traditional supply chain
HHS floats hospital pay incentives to strengthen drug supply
AstraZeneca plans independent drug supply chains for US and China, CEO says
Vitality in the Supply Chain: The Limitless Potential of ATMPs
Red Sea Shipping Disruptions Don’t Have Pharma Companies Seeing Red Just Yet

Share This Article